EG24363A - 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness - Google Patents

6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness

Info

Publication number
EG24363A
EG24363A EG2002091037A EG2002091037A EG24363A EG 24363 A EG24363 A EG 24363A EG 2002091037 A EG2002091037 A EG 2002091037A EG 2002091037 A EG2002091037 A EG 2002091037A EG 24363 A EG24363 A EG 24363A
Authority
EG
Egypt
Prior art keywords
cytokiness
pyrazolo
pyrazol
dihydro
ones
Prior art date
Application number
EG2002091037A
Other languages
English (en)
Inventor
Michael P Clark
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of EG24363A publication Critical patent/EG24363A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EG2002091037A 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness EG24363A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
EG24363A true EG24363A (en) 2009-03-04

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
EG2002091037A EG24363A (en) 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness
EG2002091039A EG24413A (en) 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines

Family Applications After (1)

Application Number Title Priority Date Filing Date
EG2002091039A EG24413A (en) 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines

Country Status (32)

Country Link
US (2) US6821971B2 (pl)
EP (3) EP1427728B1 (pl)
JP (3) JP2005504082A (pl)
KR (4) KR20040035837A (pl)
CN (3) CN1257905C (pl)
AR (3) AR037502A1 (pl)
AT (3) ATE356126T1 (pl)
AU (2) AU2002327690B2 (pl)
BR (3) BR0212673A (pl)
CA (3) CA2461071A1 (pl)
CO (3) CO5560590A2 (pl)
CY (1) CY1106398T1 (pl)
CZ (3) CZ2004345A3 (pl)
DE (3) DE60202782T2 (pl)
DK (2) DK1427732T3 (pl)
EG (2) EG24363A (pl)
ES (3) ES2282459T3 (pl)
HU (3) HUP0402500A3 (pl)
IL (3) IL160682A0 (pl)
MA (3) MA27064A1 (pl)
MX (3) MXPA04002574A (pl)
MY (2) MY129329A (pl)
NO (2) NO20041594L (pl)
NZ (3) NZ531063A (pl)
PE (3) PE20030446A1 (pl)
PL (3) PL370415A1 (pl)
PT (3) PT1427728E (pl)
RU (3) RU2278864C2 (pl)
SA (1) SA03230529B1 (pl)
SK (3) SK1492004A3 (pl)
WO (3) WO2003024971A1 (pl)
ZA (3) ZA200401260B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
JP2006501263A (ja) * 2002-09-09 2006-01-12 アムジエン・インコーポレーテツド 炎症治療用のTNF−αおよびインターロイキン低下剤としての1,4,5−置換1,2−ジヒドロ−ピラゾール−3−オンおよび3−アルコキシ−1H−ピラゾール誘導体
WO2004087696A1 (de) * 2003-04-03 2004-10-14 Merck Patent Gmbh Pirazolidin-1,2-dicarbonsaüre-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
AU2007238071B2 (en) * 2006-04-18 2012-06-07 Abbvie Inc. Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
PE20120325A1 (es) * 2009-05-19 2012-04-12 Dow Agrosciences Llc Aminopirimidinas sustituidas con arilo como agentes fungicidas
WO2016205284A1 (en) 2015-06-15 2016-12-22 Cummins Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
US20240425524A1 (en) * 2021-10-27 2024-12-26 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (pl) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
GB9303993D0 (en) * 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
CN1272324C (zh) * 1999-09-07 2006-08-30 辛根塔参与股份公司 新颖的除草剂
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
PE20030446A1 (es) 2003-07-21
AR037237A1 (es) 2004-11-03
DE60202782D1 (de) 2005-03-03
NZ531123A (en) 2006-08-31
DE60213108D1 (de) 2006-08-24
DE60218704D1 (de) 2007-04-19
CZ2004345A3 (cs) 2004-06-16
PT1427728E (pt) 2007-05-31
HUP0402500A2 (hu) 2005-03-29
RU2004111806A (ru) 2005-03-27
MY129069A (en) 2007-03-30
MXPA04002569A (es) 2004-05-31
CO5560589A2 (es) 2005-09-30
RU2004111805A (ru) 2005-04-10
US20030105084A1 (en) 2003-06-05
CN1555375A (zh) 2004-12-15
ZA200401402B (en) 2004-08-27
CZ2004361A3 (cs) 2004-07-14
BR0212905A (pt) 2004-10-13
SK1482004A3 (en) 2004-08-03
EP1427732B1 (en) 2006-07-12
US6566357B1 (en) 2003-05-20
PE20030474A1 (es) 2003-07-22
DK1427732T3 (da) 2006-10-30
CN1249066C (zh) 2006-04-05
ES2237691T3 (es) 2005-08-01
MXPA04002574A (es) 2004-06-18
EP1427728B1 (en) 2007-03-07
ATE287887T1 (de) 2005-02-15
US6821971B2 (en) 2004-11-23
HK1071366A1 (en) 2005-07-15
HUP0402500A3 (en) 2008-10-28
NZ531122A (en) 2005-09-30
EP1427732A1 (en) 2004-06-16
PT1427727E (pt) 2005-06-30
CY1106398T1 (el) 2011-10-12
PL370351A1 (pl) 2005-05-16
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
SK1502004A3 (en) 2004-09-08
RU2272040C2 (ru) 2006-03-20
CA2461073A1 (en) 2003-03-27
EG24413A (en) 2009-05-25
PL370362A1 (pl) 2005-05-16
WO2003024971A1 (en) 2003-03-27
SA03230529B1 (ar) 2008-06-21
RU2278864C2 (ru) 2006-06-27
KR100656126B1 (ko) 2006-12-12
RU2299885C2 (ru) 2007-05-27
DE60213108T2 (de) 2007-02-08
ZA200401260B (en) 2004-08-30
MXPA04002570A (es) 2004-05-31
HUP0402378A2 (hu) 2005-02-28
AU2002334641B2 (en) 2007-03-29
BR0212673A (pt) 2004-08-24
IL160682A0 (en) 2004-08-31
HUP0402378A3 (en) 2008-10-28
NO20041605L (no) 2004-06-21
CO5560579A2 (es) 2005-09-30
NZ531063A (en) 2007-08-31
JP2005504083A (ja) 2005-02-10
SK1492004A3 (en) 2004-11-03
ES2282459T3 (es) 2007-10-16
RU2004111803A (ru) 2005-10-10
CA2461071A1 (en) 2003-03-27
KR20040035836A (ko) 2004-04-29
ZA200401403B (en) 2004-08-30
KR20040035835A (ko) 2004-04-29
DE60202782T2 (de) 2006-01-19
ES2268154T3 (es) 2007-03-16
DE60218704T2 (de) 2007-11-08
BR0212716A (pt) 2004-08-03
CN1250551C (zh) 2006-04-12
PE20030430A1 (es) 2003-06-24
IL160741A0 (en) 2004-08-31
JP2005504082A (ja) 2005-02-10
KR20060036125A (ko) 2006-04-27
NO20041594L (no) 2004-06-21
MA27064A1 (fr) 2004-12-20
DK1427728T3 (da) 2007-07-09
WO2003024973A1 (en) 2003-03-27
CN1257905C (zh) 2006-05-31
KR20040035837A (ko) 2004-04-29
AR037145A1 (es) 2004-10-27
CN1556811A (zh) 2004-12-22
JP2005504081A (ja) 2005-02-10
PL370415A1 (pl) 2005-05-30
CZ2004358A3 (cs) 2004-07-14
KR100623879B1 (ko) 2006-09-19
EP1427727A1 (en) 2004-06-16
CA2461072A1 (en) 2003-03-27
CN1555379A (zh) 2004-12-15
EP1427727B1 (en) 2005-01-26
IL160742A0 (en) 2004-08-31
WO2003024970A1 (en) 2003-03-27
MY129329A (en) 2007-03-30
ATE356126T1 (de) 2007-03-15
AU2002327690B2 (en) 2006-07-20
EP1427728A1 (en) 2004-06-16
MA27066A1 (fr) 2004-12-20
HUP0500752A2 (en) 2006-01-30
MA27065A1 (fr) 2004-12-20
HK1071565A1 (en) 2005-07-22
ATE332901T1 (de) 2006-08-15
PT1427732E (pt) 2006-12-29

Similar Documents

Publication Publication Date Title
GB2383567B (en) Vehicle stability control
AU2002229976A1 (en) Imidazopyridines
GB0114424D0 (en) Improved vehicle control
IL159445A0 (en) Azaindoles
AU2002351525A1 (en) System-on-a-chip controller
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
AU2002231676A1 (en) Triazolopyrimidines
HUP0500752A2 (en) 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
AU2003255323A1 (en) Imidazo`1,2-a!pyridines
AU2002308154A1 (en) Triazolopyrimidines
AU2002343106A1 (en) Contactors
AU2002329267A1 (en) Antibacterial macrocycles
PL356668A1 (pl) Nowe podstawione pirazolo [4,3-e] diazepiny, zawierające je środki farmaceutyczne, ich zastosowaniejako produktów medycznych i sposoby ich wytwarzania
AU2002222344A1 (en) Triazolopyrimidines
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
TW505345U (en) Vehicle remote control
GB2374730B (en) Control
HK1080454A (en) 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
AU2002233664A1 (en) Naphthyridine derivative
GB2382721B (en) Contactors
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
GB0100929D0 (en) Control agents
HK1063470A (en) Azaindoles
GB0112658D0 (en) Control structure